Can a statin protect your heart during breast cancer chemotherapy?
Treatments studied
Part of Cancer, Heart & circulation, Injuries & trauma, Skin clinical trials.
This trial tests whether taking the cholesterol-lowering drug rosuvastatin can protect your heart from damage caused by a common type of chemotherapy called anthracyclines. It may help reduce the risk of heart problems during breast cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older
- You have been diagnosed with breast cancer (confirmed by imaging and biopsy)
- You are about to start your first-ever chemotherapy that includes anthracyclines
- Your heart function is normal (ejection fraction of 50% or higher)
- You are not pregnant or breastfeeding
- You have not previously taken statins and do not currently need them
- Cancer has not spread to other parts of the body
- You have no history of heart failure or cardiomyopathy
- You have no contraindications to taking statins, like severe liver problems or cyclosporine use
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks how well the heart handles anthracycline chemotherapy in breast cancer patients. It helps doctors find early signs of heart side effects so they can keep you safe during treatment.
This study tests whether a natural supplement made from grape polyphenols can help protect the heart from damage caused by certain breast cancer chemotherapy drugs. It aims to see if taking this supplement alongside treatment can reduce the risk of heart problems.
This trial studies whether a simple “remote conditioning” treatment on the arm can help protect the heart while you receive chemotherapy that includes anthracyclines. If you’re at higher risk for heart damage from chemo, this may reduce risk and help monitor heart function over time.
This study tests a method to predict and warn about heart damage from a common type of breast cancer chemotherapy. If you have HER2-positive breast cancer and will receive anthracycline drugs, this trial may help monitor your heart health.
This trial tests whether common heart medicines (statins or ACE-inhibitors) can protect the heart during cancer radiation therapy. It is for adults who are about to start chest radiation and have not taken these drugs before.
This study follows patients receiving a type of chemotherapy called anthracyclines to track how it affects the heart over time. The goal is to learn how to better protect heart health during cancer treatment.
Hear when a new Anthracycline-induced Cardiac Toxicity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.